tiprankstipranks

Rami Katkhuda Profile - LifeSci Capital Analyst

277 Followers
tipranks
Rami Katkhuda

Rami Katkhuda
LifeSci Capital

Wall Street Analyst
#418 out of 12,284 Wall Street Analysts
#1,033 out of 28,779 experts

Success Rate

49%
126 out of 255 ratings made a profit

Average Return

+26.80%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Rami Katkhuda's trades since 2025 and holding each position for 1 Year would result in 49.41% of your transactions generating a profit, with an average return of 26.8% per rating.

Stock Rating Distribution

348Ratings
98.28% Buy
1.72% Hold
0.00% Sell
Distribution of Rami Katkhuda's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Moonlake Immunotherapeutics
(MLTX)
Rating:Buy
Date:Dec 21, 2022 - Dec 21, 2023
Return:+496.20%
The most profitable rating made by Rami Katkhuda

Rami Katkhuda's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
VYNE Therapeutics
Aug 14, 2025
Hold
Reiterated
22Ratings
7%
-65.62%
Inventiva
Mar 31, 2026
Buy
Reiterated
$14.00
(258.06% Upside)
12Ratings
38%
+22.67%
Viridian Therapeutics
May 09, 2026
Buy
Reiterated
$35.00
(122.50% Upside)
46Ratings
40%
-0.57%
Dianthus Therapeutics
May 09, 2026
Buy
Reiterated
$125.00
(53.90% Upside)
22Ratings
71%
+116.21%
Amylyx Pharmaceuticals Inc
May 16, 2026
Buy
Reiterated
$24.00
(84.47% Upside)
13Ratings
29%
-4.67%
Maze Therapeutics, Inc.
May 16, 2026
Buy
Reiterated
$57.00
(141.73% Upside)
6Ratings
0%
-31.15%
MoonLake Immunotherapeutics
May 19, 2026
Buy
Reiterated
$33.00
(83.33% Upside)
39Ratings
39%
+31.40%
Mineralys Therapeutics, Inc.
Jun 01, 2026
Buy
Assigned
$54.00
(140.00% Upside)
24Ratings
68%
+59.91%
Disc Medicine
Jun 02, 2026
Buy
Reiterated
$100.00
(51.98% Upside)
36Ratings
61%
+13.06%
Vera Therapeutics
Jun 02, 2026
Buy
Reiterated
$90.00
(183.46% Upside)
36Ratings
54%
+58.45%
List of latest recommendations made by Rami Katkhuda. Click to expand and see Rami Katkhuda's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Rami Katkhuda activity FAQ

What is the performance of Rami Katkhuda's recommendations?
The percentage of profitable recommendations made by Rami Katkhuda is 49%, and the average return per transaction is 26.80%.
    What stocks does Rami Katkhuda cover?
    Rami Katkhuda mostly covers VRDN ,ELDN ,MLTX stocks.
      What was Rami Katkhuda's most profitable rating?
      Rami Katkhuda’s most profitable ratings was a buy on MLTX stock on Dec 21, 2022 - Dec 21, 2023. The return on the trade was +496.20%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here